Hanseatic Management Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-26
Closed -$7K 220
2020
Q3
$7K Buy
+26
New +$7.49K 0.02% 152
2019
Q1
Sell
-3,074
Closed -$999K 322
2018
Q4
$999K Hold
3,074
1.35% 13
2018
Q3
$1.38M Hold
3,074
1.29% 13
2018
Q2
$1.26M Hold
3,074
1.08% 25
2018
Q1
$895K Hold
3,074
0.86% 35
2017
Q4
$576K Buy
+3,074
New +$574K 0.58% 77
2017
Q1
Sell
-9,177
Closed -$1.03M 440
2016
Q4
$1.03M Sell
9,177
-13,927
-60% -$1.61M 0.58% 66
2016
Q3
$2.97M Sell
23,104
-37
-0.2% -$4.43K 1.06% 24
2016
Q2
$2.53M Sell
23,141
-2,322
-9% -$231K 0.96% 28
2016
Q1
$2.41M Sell
25,463
-779
-3% -$65.8K 0.88% 44
2015
Q4
$2.37M Sell
26,242
-96
-0.4% -$8.15K 0.82% 43
2015
Q3
$2.44M Buy
26,338
+10,543
+67% +$929K 0.76% 39
2015
Q2
$1.04M Buy
15,795
+14,924
+1,713% +$992K 0.46% 88
2015
Q1
$62K Buy
+871
New +$47.3K 0.03% 169

Other funds holding ABMD

Hanseatic Management Services's ABMD Position: Q4 2020 in Review

Hanseatic Management Services sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 26 shares — an estimated $7K sold.

Hanseatic Management Services first reported a position in ABMD in Q1 2015 and held it in 14 quarters. The position peaked at $2.97M in Q3 2016. 499 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Hanseatic Management Services reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Hanseatic Management Services sold 26 Abiomed Inc shares in Q4 2020, an estimated $7K.
  • Hanseatic Management Services first reported a position in Abiomed Inc in Q1 2015 and held it in 14 quarters.
  • Hanseatic Management Services's Abiomed Inc position peaked at $2.97M in Q3 2016.
  • 499 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Hanseatic Management Services's 13F filing for Q4 2020, filed 29 Jan 2021.